Biotech Startups

Azul Bio is a public benefit company that develops live biotherapeutics—custom microbial-based treatments—to help coral reefs resist heat-induced bleaching, disease, and pollution. It also provides coral treatment application, rapid biotherapeutic development, and marine genomics and microbiome analysis services for reef monitoring, coral aquaculture, and marine research.

1 investor

Azura Ophthalmics develops a new therapeutic class of ophthalmic keratolytics aimed at treating lid margin and ocular surface diseases and other underserved ophthalmic conditions. The company applies drug development expertise to address the core pathophysiology of these eye conditions.

1 investor

Azurecell is an early-stage company focused on restoring neural function, with no further product or service details disclosed on the page.

1 investor

Strategic Investment Group provides outsourced investment management for institutions, including strategic asset allocation policy design and back-office support. It offers customized investment solutions tailored to each institution's objectives, mission, and risk tolerance.

1 investor

BabyBiom is a Polish brand developing probiotic cosmetics for infants, newborns, and children that support the skin's natural microbiome from the first days of life, with particular focus on babies born via cesarean section. The company combines microbiology, biotechnology, and cosmetology, working on R&D projects to create skincare products.

1 investor

BacAlt uses fermentation to convert agricultural waste into fully natural bacterial biopolymers that replace synthetic ingredients. It supplies these functional biopolymers to formulators across sectors including home care, cosmetics, oral care, agri-chem, nutraceuticals, and pharmaceuticals.

1 investor

Bacta develops an AI-powered bioproduction platform that uses microorganisms to produce industrial ingredients, starting with astaxanthin. Its ingredients are offered in multiple forms with traceability for the cosmetics, human nutrition, and animal nutrition markets.

1 investor

Bactolife develops Binding Proteins for use in functional foods for humans and in animal feed, aimed at supporting healthy digestion and livestock health. It positions its products as affordable, science-based solutions sold to food producers and the animal feed industry.

1 investor

Baltic Sandbox Ventures is an early-stage investor and program operator running a 7-week equity-free incubation, a 6-month acceleration (Business Development Lab), and seed investments for deep-tech founders. It backs R&D-driven teams with scientific backgrounds building in domains such as AI/ML, life sciences (BioTech, MedTech), and hardware (robotics, IoT, space).

1 investor

BAMF Health describes itself as a global team working in healthcare. The page provides no concrete detail about the company's products or services.

1 investor

Baobab AiBio develops therapeutics through a drug discovery pipeline (including candidates GF-103 and GF-203) using cryo-electron microscopy, protein engineering, and quantum computing. It also offers services such as structure determination, electron tomography, protein engineering, and HPC-based modeling.

1 investor

Baqta develops fermented, nutraceutical-grade powder ingredients produced through controlled fermentation of selected raw materials. The customizable powders serve as dietary supplements, food ingredients, animal nutrition products, and inputs for cosmetics.

1 investor

Barcode Nanotech develops nanoparticle-based delivery vehicles for RNA/DNA therapeutics and vaccines, using proprietary lipids and an in vivo and AI-based screening platform to target specific tissues and cells beyond the liver. Its platform aims at selective indications such as hard-to-treat cancers and metabolic diseases.

1 investor

Barnstorm Foundry is a venture studio focused on building and launching life sciences and biotech companies, drawing on advisors in talent acquisition, commercialization, IP, corporate law, and biosensor technology. It supports ventures translating research such as continuous monitoring and real-time physiological measurement into health products.

1 investor

Barricade Therapeutics is a clinical-stage oncology company developing BT-1501, an investigational once-daily oral small-molecule EBP inhibitor built on its TASIN platform to target genetic drivers of colorectal cancer. The therapy is aimed at patients with advanced and metastatic colorectal cancer and is advancing toward IND submission and first-in-human clinical trials.

1 investor

baseclick provides click chemistry solutions and nucleic acid research products manufactured in Germany. The company serves scientists and researchers globally with application-driven products for reproducible nucleic acid research.

1 investor

Baseimmune develops active immunotherapies using computational design and protein engineering to create custom antigens aimed at chronic diseases. The company operates in the biotech and therapeutics space.

1 investor

Baseline AI provides AI-powered automation for generating clinical trial documentation and data management artifacts from study protocols, including data collection forms, database schemas, validation rules, statistical code, and data mappings—reducing the manual effort typically required across multiple teams at pharmaceutical companies.

1 investor

Baseline is a biotech company focused on metabolism, obesity, incretins, and GLP-1-based strategies for substance use disorders, drawing on drug development and addiction medicine expertise. It develops therapies and brings drug candidates through clinical and regulatory pathways.

1 investor

baSeq offers an AI agent network that autonomously orchestrates bioinformatics workflows on raw, multi-modal experimental data, executing analysis steps and generating documentation with scientist approval at each critical decision point. It targets life-science and biotech organizations and can be deployed on-prem, in a private cloud, or on baSeq infrastructure.

1 investor

BASi supplies analytical instrumentation and scientific research services to pharmaceutical companies developing new drugs. The company aims to accelerate drug development through improved instrumentation and research capabilities.

1 investor

Baxiva is a biotechnology startup developing glycoconjugate vaccines to prevent bacterial infections with high clinical burden and antimicrobial resistance. Its lead program targets urinary tract and invasive infections caused by Escherichia coli.

1 investor

BayOmics is a proteomics company founded in January 2022 that develops proprietary technologies and tools for protein research to advance disease diagnosis and drug discovery. The company offers research services, reagent kits, instrument platforms, and integrated solutions for applications including tissue microenvironment analysis, biomarker development, and drug target identification.

1 investor

BBI Solutions provides reagents and biochemical products for in vitro diagnostics and life sciences teams, supporting assay development and diagnostic test manufacturing. The company serves IVD manufacturers and life sciences researchers with enzymes, gold colloids, and recombinant reagents.

1 investor